The immunosuppressant LF 15-0195 prevents experimental autoimmune myasthenia gravis in Brown-Norway rats

Saved in:
Bibliographic Details
Published inTransplantation proceedings Vol. 34; no. 7; pp. 2962 - 2965
Main Authors Duplan, V, Dutartre, P, Druet, P, Saoudi, A
Format Journal Article Conference Proceeding
LanguageEnglish
Published New York, NY Elsevier Inc 01.11.2002
Elsevier Science
Subjects
Animals
Antibody Formation - drug effects
B-Lymphocytes - drug effects
B-Lymphocytes - immunology
Biological and medical sciences
Disease Models, Animal
Diseases of striated muscles. Neuromuscular diseases
Guanidines - pharmacology
Immunomodulators
Immunosuppressive Agents - pharmacology
Male
Medical sciences
Myasthenia Gravis - classification
Myasthenia Gravis - immunology
Myasthenia Gravis - prevention & control
Neurology
Pharmacology. Drug treatments
Rats
Rats, Inbred BN
T-Lymphocytes - drug effects
T-Lymphocytes - immunology
Autoimmunity
Animal model
Neuromuscular diseases
Nervous system diseases
Rat
Rodentia
Prevention
Vertebrata
Chemotherapy
Mammalia
Myasthenia gravis
Treatment
Animal
Immunosuppressive agent
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0041-1345
1873-2623
DOI:10.1016/S0041-1345(02)03504-2